Autism is a severe neurodevelopmental disorder with a strong genetic basis.The methyl-CpG binding protein 2 gene (MECP2) is a dosage-sensitive gene in brain development and has been implicated as a candidate gene for autism. Duplication of the MECP2 gene has been reported in a few boys with autistic features. To further investigate the association of MECP2 duplication with autism, the authors performed real-time quantitative polymerase chain reaction (PCR) to detect copy number variations of the MECP2 gene in 82 autistic boys. No copy number variation was found in these patients, indicating that duplication of the MECP2 gene is not frequent in autistic patients. The authors consider that duplication of the MECP2 gene has no major effect on the susceptibility to autism. Replication of studies in a large-sized sample and a well-characterized subgroup of autism are warranted to further identify the association of MECP2 gene duplication with autism.
Amir RE, Vand VI, Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999 ;23:185-188.
2.
Lord C., Shulman C., DiLavore P.Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry. 2004; 45:936-955.
3.
Rogers SJDevelopmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev. 2004;10:139-143.
4.
Vourc’h P., Bienvenu T., Beldjord C., et al. No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. J Hum Genet. 2001;9:556-558.
5.
Lobo-Menendez F., Sossey-Alaoui K., Bell JM, et al. Absence of MeCP2 mutations in patients from the South Carolina autism project. Am J Med Genet. 2003;17B:97-101.
6.
Xi CY, Ma HW, Lu Y., et al. MeCP2 gene mutation analysis in autistic boys with developmental regression. Psychiatr Genet. 2007;17:113-116.
7.
Santos M., Temudo T., Kay T., et al. Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients. J Child Neurol. 2009;24: 49-55.
8.
Collins AL, Levenson JM, Vilaythong AP, et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet. 2004;13:2679-2689.
9.
Luikenhuis S. , Giacometti E., Beard CF, Jaenisch R.Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci USA. 2004;101:6033-6038.
10.
Van Esch H. , Bauters M., Ignatius J., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet. 2005;77:442-453.
11.
Del Gaudio D., Fang P., Scaglia F., e al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med. 2006;8:784-792.
12.
Ramocki M., Sarika UP, Tavyev YJ, et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2duplication syndrome. Ann Neurology . 2009;66: 771-782.
13.
Ariani F., Mari F., Pescucci C., et al. Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: report of one case of MECP2 deletion and one case of MECP2 duplication. Human Mutation. 2004;24: 172-177.
14.
Echenne B., Roubertie A., Lugtenberg D., et al. Neurologic aspects of MECP2 gene duplication in male patients . Pediatr Neurol. 2009;41:187-191.
15.
Aarskog NK, Vedeler CAReal-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet. 2000; 107:494-498.
16.
Thiel CT, Kraus C., Rauch A., et al. A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions leading to HMSN/HNPP. Eur J Hum Genet. 2003;11:170-178.
17.
Van Esch H.MECP2 duplication syndrome. In: Pagon RA, Bird TC, Dolan CR, Stephens K, eds. Gene Reviews. Seattle, WAUniversity of Washington, Seattle; 2008:18.
18.
Ramocki MB, Tavyev YJ, Peters SUThe MECP2 duplication syndrome. Am J Med Genet. 2010;152A:1079-1088.
19.
Friez MJ, Jones JR, Clarkson K., et al. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics . 2006;118: e1687-1695.
20.
Smyk M., Obersztyn E., Nowakowska B., et al. Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections . Am J Med Genet. 2007;147B:799-806.
21.
Prescott TE, Rodningen OK, Bjornstad A., Stray-Pedersen A.Two brothers with a microduplication including the MECP2 gene: rapid head growth in infancy and resolution of susceptibility to infection. Clin Dysmorphol. 2008;18:78-82.
22.
Kirk EP, Malaty-Brevaud V., Martini N., et al. The clinical variability of the MECP2 duplication syndrome: description of two families with duplications excluding L1CAM and FLNA. Clin Genet. 2009;75:301-303.
23.
Chahrour M. , Jung SY, Shaw C., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;30:1224-1229.
24.
Loat CS, Curran S., Lewis CM, et al. Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism. Genes Brain Behav. 2008;7:754-760.
